ICES, Toronto, Canada.
Public Health Ontario, Toronto, Canada.
Euro Surveill. 2024 Feb;29(8). doi: 10.2807/1560-7917.ES.2024.29.8.2300239.
BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe examined the association between time since vaccination and laboratory-confirmed influenza to assess the change in influenza vaccine protection over time.MethodsUsing linked laboratory and health administrative databases in Ontario, Canada, we identified community-dwelling individuals aged ≥ 6 months who received an influenza vaccine before being tested for influenza by RT-PCR during the 2010/11 to 2018/19 influenza seasons. We estimated the adjusted odds ratio (aOR) for laboratory-confirmed influenza by time since vaccination (categorised into intervals) and for every 28 days.ResultsThere were 53,065 individuals who were vaccinated before testing for influenza, with 10,264 (19%) influenza-positive cases. The odds of influenza increased from 1.05 (95% CI: 0.91-1.22) at 42-69 days after vaccination and peaked at 1.27 (95% CI: 1.04-1.55) at 126-153 days when compared with the reference interval (14-41 days). This corresponded to 1.09-times increased odds of influenza every 28 days (aOR = 1.09; 95% CI: 1.04-1.15). Individuals aged 18-64 years showed the greatest decline in protection against influenza A(H1N1) (aOR = 1.26; 95% CI: 0.97-1.64), whereas for individuals aged ≥ 65 years, it was against influenza A(H3N2) (aOR = 1.20; 95% CI: 1.08-1.33). We did not observe evidence of waning vaccine protection for individuals aged < 18 years.ConclusionsInfluenza vaccine protection wanes during an influenza season. Understanding the optimal timing of vaccination could ensure robust protection during seasonal influenza activity.
背景
季节性流感疫苗的免疫效力会随时间衰减,导致在流感高峰期间保护效果不理想。然而,使用接种疫苗和未接种疫苗的个体评估免疫效力衰减的疫苗有效性研究存在偏倚。
目的
我们旨在通过检测接种疫苗者和未接种疫苗者的时间与流感确诊病例之间的相关性,评估流感疫苗保护作用随时间的变化。
方法
我们利用加拿大安大略省的实验室和健康管理数据库,确定了在 2010/11 至 2018/19 流感季节,在接受实时聚合酶链反应(RT-PCR)检测流感之前,接受流感疫苗接种的年龄≥6 个月的社区居住个体。我们根据时间(分为间隔)和每 28 天,评估接种疫苗与实验室确诊流感之间的调整后比值比(aOR)。
结果
共有 53065 名个体在接受流感检测之前接种了疫苗,其中有 10264 例(19%)流感阳性病例。与参考间隔(14-41 天)相比,接种后 42-69 天的流感发病率从 1.05(95%CI:0.91-1.22)上升到接种后 126-153 天的峰值 1.27(95%CI:1.04-1.55)。这相当于每 28 天增加 1.09 倍的流感发病风险(aOR=1.09;95%CI:1.04-1.15)。18-64 岁人群的甲型 H1N1 流感保护作用下降最大(aOR=1.26;95%CI:0.97-1.64),而 65 岁及以上人群的甲型 H3N2 流感保护作用下降(aOR=1.20;95%CI:1.08-1.33)。我们没有发现 18 岁以下人群的流感疫苗保护作用随时间衰减的证据。
结论
流感疫苗的保护作用在流感季节会随时间衰减。了解疫苗接种的最佳时机可以确保在季节性流感活动期间获得强大的保护作用。